Addex Therapeutics Ltd ADXN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.66M | -- | -- | -- | 9.46M |
| Total Depreciation and Amortization | 49.70K | -- | -- | -- | 215.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.41M | -- | -- | -- | -11.90M |
| Change in Net Operating Assets | 189.70K | -- | -- | -- | -1.98M |
| Cash from Operations | -3.01M | -- | -- | -- | -4.20M |
| Capital Expenditure | -- | -- | -- | -- | -1.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.80K | -- | -- | -- | 5.14M |
| Cash from Investing | 70.80K | -- | -- | -- | 5.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -38.00K | -- | -- | -- | -8.80K |
| Issuance of Common Stock | 862.80K | -- | -- | -- | 5.60K |
| Repurchase of Common Stock | -28.10K | -- | -- | -- | -22.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.00K | -- | -- | -- | 64.30K |
| Cash from Financing | 996.20K | -- | -- | -- | 42.90K |
| Foreign Exchange rate Adjustments | 5.70K | -- | -- | -- | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 338.20K |
| Net Change in Cash | -1.94M | -- | -- | -- | 1.30M |